US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VictoryShares Pioneer Asset-Based Income ETF

24.80

+0.03000.12%

Post-market: 24.800.00000.00%19:34 EDT

Volume:141

Turnover:3.50K

Market Cap:56.42M

PE:- -

High:24.80

Open:24.80

Low:24.80

Close:24.77

52wk High:25.27

52wk Low:24.76

Shares:2.28M

Float Shares:2.28M

Volume Ratio:1.09

T/O Rate:0.01%

Dividend:1.54

Dividend Rate:6.20%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aegon warns red tape is blocking pension investment spree

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

Press Release: MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ABI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","market":"US","secType":"STK","nameCN":"VictoryShares Pioneer Asset-Based Income ETF","latestPrice":24.8,"timestamp":1784923200000,"preClose":24.77,"halted":0,"volume":141,"hourTrading":{"tag":"盘后","latestPrice":24.8,"preClose":24.8,"latestTime":"19:34 EDT","volume":5,"amount":124,"timestamp":1784936043072,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0012111425111021857,"floatShares":2275000,"shares":2275000,"eps":0,"marketStatus":"Market Closed","change":0.03,"latestTime":"07-24 16:00:00 EDT","open":24.8,"high":24.8,"low":24.8,"amount":3503.8500000000004,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":24.77,"sharesOutstanding":2275000,"nav":24.76025,"aum":56329682.5,"dividendRate":0.062024,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.8,"preClose":24.8,"latestTime":"19:34 EDT","volume":5,"amount":124,"timestamp":1784936043072,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0896440921004282},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","floatShares":2275000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0896440921004282,"shares":2275000,"dividePrice":1.5382,"high":24.8,"amplitude":0,"preClose":24.77,"low":24.8,"week52Low":24.76,"pbRate":"--","week52High":25.27,"institutionHeld":0,"latestPrice":24.8,"eps":0,"divideRate":0.062024,"volume":141,"delay":0,"ttmEps":0,"open":24.8,"prevYearClose":24.835,"prevWeekClose":24.78,"prevMonthClose":24.87,"prevQuarterClose":24.87,"fiveDayClose":24.78,"twentyDayClose":24.87,"sixtyDayClose":24.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABI\",params:#limit:5,,,undefined,":[{"date":"2026-07-09","symbol":"ABI","amount":0.138686,"announcedDate":"2026-07-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-09","defaultRemindTime":1783603800000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-10","payableDate":"2026-07-09","currency":"USD","dateTimestamp":1783569600000,"payDate":"2026-07-10"},{"date":"2026-06-09","symbol":"ABI","amount":0.123144,"announcedDate":"2026-06-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-09","defaultRemindTime":1781011800000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-10","payableDate":"2026-06-09","currency":"USD","dateTimestamp":1780977600000,"payDate":"2026-06-10"},{"date":"2026-05-08","symbol":"ABI","amount":0.126,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-08","defaultRemindTime":1778247000000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-05-08","currency":"USD","dateTimestamp":1778212800000,"payDate":"2026-05-11"},{"date":"2026-04-09","symbol":"ABI","amount":0.1361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-09","defaultRemindTime":1775741400000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-10","payableDate":"2026-04-09","currency":"USD","dateTimestamp":1775707200000,"payDate":"2026-04-10"},{"date":"2026-03-10","symbol":"ABI","amount":0.130438,"announcedDate":"2026-03-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-10","defaultRemindTime":1773149400000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-11","payableDate":"2026-03-10","currency":"USD","dateTimestamp":1773115200000,"payDate":"2026-03-11"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABI\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-10","recordDate":"2025-07-10","paymentDate":"2025-07-11","value":0.01517,"currency":"USD"},{"executeDate":"2025-08-06","recordDate":"2025-08-06","paymentDate":"2025-08-07","value":0.083425,"currency":"USD"},{"executeDate":"2025-09-08","recordDate":"2025-09-08","paymentDate":"2025-09-09","value":0.132826,"currency":"USD"},{"executeDate":"2025-10-09","recordDate":"2025-10-09","paymentDate":"2025-10-10","value":0.146893,"currency":"USD"},{"executeDate":"2025-11-07","recordDate":"2025-11-07","paymentDate":"2025-11-10","value":0.122586,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651415534","title":"Aegon warns red tape is blocking pension investment spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2651415534","media":"cityam","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651415534?lang=en_us&edition=fundamental","pubTime":"2026-07-16 13:00","pubTimestamp":1784178000,"startTime":"0","endTime":"0","summary":"One Mansion House signatory has raised concerns over regulatory barriers  Aegon has warned that regulation is holding back some of Britain’s top pension fund managers from pumping cash into the country’s start-ups and unlisted companies.The pension giant, which manages 160bn of assets in the UK alone, was one of 11 companies alongside Aviva and Legal & General to commit to investing five per cent of their assets in unlisted equities by 2030. However, Aegon has warned that regulatory hurdles could throw timelines into doubt as the City marks the three year anniversary of the agreement’s signing.“While we have made meaningful progress, we remain concerned about the timeline to the 2030 Mansion House Compact target,” Lorna Blyth, managing director, investment proposition at Aegon, told City AM.Providers said “managing appropriate fee structures remains problematic”, as certain models used in private capital markets are “financially unfeasible”.To protect savers from having their pension p","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/02/London-insurance-e1770395080662.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/02/London-insurance-e1770395080662.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/aegon-warns-red-tape-is-blocking-pension-investment-spree/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/aegon-warns-red-tape-is-blocking-pension-investment-spree/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["ABI","ITDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645489021","title":"MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2645489021","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645489021?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126000,"startTime":"0","endTime":"0","summary":"The IRIS Phase 2 trial did not meet its primary endpoint in social communication deficits associated with ASD A prespecified analysis in adolescents with moderate to severe baseline irritability (ABC-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315170/0/en/MapLight-Announces-Topline-Results-from-Phase-2-IRIS-Study-for-ML-004-in-Autism-Spectrum-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","ASD","ABI","BK4018","SPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637163903","title":"Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2637163903","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637163903?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:00","pubTimestamp":1779447600,"startTime":"0","endTime":"0","summary":"– Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 –– Builds on completed Phase 1a study and ongoing development in HDV – SOUTH SAN FRANCISCO, Ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300036/16259/en/Assembly-Biosciences-Announces-Expansion-of-ABI-6250-Clinical-Development-Into-Cholestatic-Liver-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HDV","PBC","BK4585","BK4139","ABI","ASMB","PSC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723955","title":"Press Release: MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723955?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789100,"startTime":"0","endTime":"0","summary":"-- Enrollment completed in ML-007C-MA's Phase 2 ZEPHYR trial in. schizophrenia, with topline results expected by mid-August 2026. -- Last patient visit completed for ML-004's Phase 2 IRIS trial in autism. -- Enrollment ongoing in ML-007C-MA's Phase 2 VISTA trial in Alzheimer's. disease psychosis, with topline results expected in the second half of. -- Ended the quarter with $395.2 million in cash, cash equivalents and. investments, which is expected to fund operations through 2027. \"We are continuing to see strong momentum across our clinical portfolio, including completion of enrollment in the Phase 2 ZEPHYR and IRIS trials, \" said Chris Kroeger, co-Founder and Chief Executive Officer of the Company. \"With topline results from both studies expected by mid-August, continued advancement of our VISTA trial in Alzheimer's disease psychosis and progress across our early-stage pipeline, MapLight is entering an important inflection point in our mission to improve the lives of patients living","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4106","LU2506951958.HKD","LU1363072403.SGD","LU0494093205.USD","LU1868837136.USD","ADP","LU0061474705.USD","LU0690374615.EUR","MA","LU1236620750.USD","LU2404859741.USD","IE00B775H168.HKD","SGXZ81514606.USD","LU1712237335.SGD","LU0820561818.USD","LU2168564149.EUR","LU0868494617.USD","LU0234572021.USD","IE000SO60NU8.SGD","LU0957791311.USD","LU0950375773.USD","SG9999000418.SGD","LU1037948897.HKD","LU1228905540.USD","LU2023250330.USD","LU2361044865.SGD","LU2552382132.HKD","LU0198837287.USD","IE00B4JS1V06.HKD","LU0061474960.USD","MPLT","IE000MB6IJN5.SGD","LU1803068979.SGD","LU0823421416.USD","IE00B1XK9C88.USD","BK4566","BK4227","LU0965509101.SGD","LU0390134368.USD","LU0170899867.USD","LU1718418525.SGD","LU0965509283.SGD","ABI","LU1989772840.SGD","IE00BFSS7M15.SGD","LU0094547139.USD","LU2756315664.SGD","LU2896262040.SGD","LU1236620834.HKD","IE000WAW04H5.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ABI\",params:#limit:6,delay:false,,,undefined,":[]}}